Terms: = Colorectal cancer AND NONO, Q15233, 4841, ENSG00000147140, NRB54, P54NRB, NMT55, P54
19 results:
1. [Construction of a model based on multipoint full-layer puncture biopsy for predicting pathological complete response after neoadjuvant therapy for locally advanced rectal cancer].
Jin Y; Zhai ZW; Sun LT; Xia PD; Hu H; Jiang CQ; Zhao BC; Qu H; Qian Q; Dai Y; Yao HW; Wang ZJ; Han JG
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):403-411. PubMed ID: 38644246
[No Abstract] [Full Text] [Related]
2. DNA damage-induced paraspeckle formation enhances DNA repair and tumor radioresistance by recruiting ribosomal protein P0.
Wang YL; Zhao WW; Bai SM; Ma Y; Yin XK; Feng LL; Zeng GD; Wang F; Feng WX; Zheng J; Wang YN; Zeng B; Liu Q; Hung MC; Wan XB
Cell Death Dis; 2022 Aug; 13(8):709. PubMed ID: 35974014
[TBL] [Abstract] [Full Text] [Related]
3. SPHK1 contributes to cisplatin resistance in bladder cancer cells via the nono/STAT3 axis.
Qin Z; Tong H; Li T; Cao H; Zhu J; Yin S; He W
Int J Mol Med; 2021 Nov; 48(5):. PubMed ID: 34549307
[TBL] [Abstract] [Full Text] [Related]
4. PRMT1 enhances oncogenic arginine methylation of nono in colorectal cancer.
Yin XK; Wang YL; Wang F; Feng WX; Bai SM; Zhao WW; Feng LL; Wei MB; Qin CL; Wang F; Chen ZL; Yi HJ; Huang Y; Xie PY; Kim T; Wang YN; Hou JW; Li CW; Liu Q; Fan XJ; Hung MC; Wan XB
Oncogene; 2021 Feb; 40(7):1375-1389. PubMed ID: 33420374
[TBL] [Abstract] [Full Text] [Related]
5. Blood group O is a risk factor for delayed post-polypectomy bleeding.
Furuhashi H; Dobashi A; Tamai N; Shimamoto N; Kobayashi M; Ono S; Hara Y; Matsui H; Kamba S; Horiuchi H; Koizumi A; Ohya TR; Kato M; Ikeda K; Arakawa H; Sumiyama K
Surg Endosc; 2021 Dec; 35(12):6882-6891. PubMed ID: 33258034
[TBL] [Abstract] [Full Text] [Related]
6. DEAD-Box Protein RNA-Helicase DDX6 Regulates the Expression of HER2 and FGFR2 at the Post-Transcriptional Step in Gastric cancer Cells.
Tajirika T; Tokumaru Y; Taniguchi K; Sugito N; Matsuhashi N; Futamura M; Yanagihara K; Akao Y; Yoshida K
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29987267
[TBL] [Abstract] [Full Text] [Related]
7. Oncogene RNA helicase DDX6 promotes the process of c-Myc expression in gastric cancer cells.
Taniguchi K; Iwatsuki A; Sugito N; Shinohara H; Kuranaga Y; Oshikawa Y; Tajirika T; Futamura M; Yoshida K; Uchiyama K; Akao Y
Mol Carcinog; 2018 May; 57(5):579-589. PubMed ID: 29314290
[TBL] [Abstract] [Full Text] [Related]
8. Inactivation of JNK2 as carcinogenic factor in colitis-associated and sporadic colorectal carcinogenesis.
Lessel W; Silver A; Jechorek D; Guenther T; Roehl FW; Kalinski T; Roessner A; Poehlmann-Nitsche A
Carcinogenesis; 2017 May; 38(5):559-569. PubMed ID: 28383667
[TBL] [Abstract] [Full Text] [Related]
9. Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and nono.
Yang P; Chen T; Xu Z; Zhu H; Wang J; He Z
Oncotarget; 2016 Jul; 7(27):42183-42194. PubMed ID: 27259250
[TBL] [Abstract] [Full Text] [Related]
10. ABO blood groups and risk of cancer: a systematic review and meta-analysis.
Zhang BL; He N; Huang YB; Song FJ; Chen KX
Asian Pac J Cancer Prev; 2014; 15(11):4643-50. PubMed ID: 24969898
[TBL] [Abstract] [Full Text] [Related]
11. Triplex DNA-binding proteins are associated with clinical outcomes revealed by proteomic measurements in patients with colorectal cancer.
Nelson LD; Bender C; Mannsperger H; Buergy D; Kambakamba P; Mudduluru G; Korf U; Hughes D; Van Dyke MW; Allgayer H
Mol Cancer; 2012 Jun; 11():38. PubMed ID: 22682314
[TBL] [Abstract] [Full Text] [Related]
12. nono and RALY proteins are required for YB-1 oxaliplatin induced resistance in colon adenocarcinoma cell lines.
Tsofack SP; Garand C; Sereduk C; Chow D; Aziz M; Guay D; Yin HH; Lebel M
Mol Cancer; 2011 Nov; 10():145. PubMed ID: 22118625
[TBL] [Abstract] [Full Text] [Related]
13. ABO blood group and risk of colorectal cancer.
Khalili H; Wolpin BM; Huang ES; Giovannucci EL; Kraft P; Fuchs CS; Chan AT
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):1017-20. PubMed ID: 21415359
[TBL] [Abstract] [Full Text] [Related]
14. NO-releasing NSAIDs suppress NF-κB signaling in vitro and in vivo through S-nitrosylation.
Chattopadhyay M; Goswami S; Rodes DB; Kodela R; Velazquez CA; Boring D; Crowell JA; Kashfi K
Cancer Lett; 2010 Dec; 298(2):204-11. PubMed ID: 20674154
[TBL] [Abstract] [Full Text] [Related]
15. Knockdown of RCK/p54 expression by RNAi inhibits proliferation of human colorectal cancer cells in vitro and in vivo.
Lin F; Wang R; Shen JJ; Wang X; Gao P; Dong K; Zhang HZ
Cancer Biol Ther; 2008 Oct; 7(10):1669-76. PubMed ID: 18769115
[TBL] [Abstract] [Full Text] [Related]
16. Proteomic identification of a PSF/p54nrb heterodimer as RNF43 oncoprotein-interacting proteins.
Miyamoto K; Sakurai H; Sugiura T
Proteomics; 2008 Jul; 8(14):2907-10. PubMed ID: 18655028
[TBL] [Abstract] [Full Text] [Related]
17. Sphinganine causes early activation of JNK and p38 MAPK and inhibition of AKT activation in HT-29 human colon cancer cells.
Ahn EH; Schroeder JJ
Anticancer Res; 2006; 26(1A):121-7. PubMed ID: 16475687
[TBL] [Abstract] [Full Text] [Related]
18. Co-overexpression of DEAD box protein rck/p54 and c-myc protein in human colorectal adenomas and the relevance of their expression in cultured cell lines.
Hashimoto K; Nakagawa Y; Morikawa H; Niki M; Egashira Y; Hirata I; Katsu K; Akao Y
Carcinogenesis; 2001 Dec; 22(12):1965-70. PubMed ID: 11751426
[TBL] [Abstract] [Full Text] [Related]
19. Overexpression of rck/p54, a DEAD box protein, in human colorectal tumours.
Nakagawa Y; Morikawa H; Hirata I; Shiozaki M; Matsumoto A; Maemura K; Nishikawa T; Niki M; Tanigawa N; Ikegami M; Katsu K; Akao Y
Br J Cancer; 1999 May; 80(5-6):914-7. PubMed ID: 10360675
[TBL] [Abstract] [Full Text] [Related]
